Cargando…
The COVID-19 pandemic: a catalyst to improve clinical trials
The COVID-19 pandemic has provided the vital stepping stones to improve how clinical trials are conducted. We provide an overview of the major changes to the clinical trial process instigated by the pandemic and suggest ways to make these changes sustainable.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461742/ https://www.ncbi.nlm.nih.gov/pubmed/32873977 http://dx.doi.org/10.1038/s41569-020-00439-7 |
| _version_ | 1783576782081884160 |
|---|---|
| author | Gaba, Prakriti Bhatt, Deepak L. |
| author_facet | Gaba, Prakriti Bhatt, Deepak L. |
| author_sort | Gaba, Prakriti |
| collection | PubMed |
| description | The COVID-19 pandemic has provided the vital stepping stones to improve how clinical trials are conducted. We provide an overview of the major changes to the clinical trial process instigated by the pandemic and suggest ways to make these changes sustainable. |
| format | Online Article Text |
| id | pubmed-7461742 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74617422020-09-02 The COVID-19 pandemic: a catalyst to improve clinical trials Gaba, Prakriti Bhatt, Deepak L. Nat Rev Cardiol Comment The COVID-19 pandemic has provided the vital stepping stones to improve how clinical trials are conducted. We provide an overview of the major changes to the clinical trial process instigated by the pandemic and suggest ways to make these changes sustainable. Nature Publishing Group UK 2020-09-01 2020 /pmc/articles/PMC7461742/ /pubmed/32873977 http://dx.doi.org/10.1038/s41569-020-00439-7 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Comment Gaba, Prakriti Bhatt, Deepak L. The COVID-19 pandemic: a catalyst to improve clinical trials |
| title | The COVID-19 pandemic: a catalyst to improve clinical trials |
| title_full | The COVID-19 pandemic: a catalyst to improve clinical trials |
| title_fullStr | The COVID-19 pandemic: a catalyst to improve clinical trials |
| title_full_unstemmed | The COVID-19 pandemic: a catalyst to improve clinical trials |
| title_short | The COVID-19 pandemic: a catalyst to improve clinical trials |
| title_sort | covid-19 pandemic: a catalyst to improve clinical trials |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461742/ https://www.ncbi.nlm.nih.gov/pubmed/32873977 http://dx.doi.org/10.1038/s41569-020-00439-7 |
| work_keys_str_mv | AT gabaprakriti thecovid19pandemicacatalysttoimproveclinicaltrials AT bhattdeepakl thecovid19pandemicacatalysttoimproveclinicaltrials AT gabaprakriti covid19pandemicacatalysttoimproveclinicaltrials AT bhattdeepakl covid19pandemicacatalysttoimproveclinicaltrials |